Oncology Channel
Featured Content
Increasing Effectiveness of Chemo for Metastatic Colorectal Cancer - from Oncology Times
Colorectal cancer (CRC) is the third most common cancer in men (10% of the total) and the second in women (9.2%), with more than 1.8 million new cases identified every year globally accounting for about one in 10 cancer cases and deaths.
DeVita, Helmman, and Rosenberg's Cancer: Principles & Practice of Oncology
Colorectal cancer (CRC) is the third most common cancer in men (10% of the total) and the second in women (9.2%), with more than 1.8 million new cases identified every year globally accounting for about one in 10 cancer cases and deaths.
Sacituzumab govitecan-hziy for triple-negative breast cancer - from the Lancet Oncology
Standard chemotherapy is associated with low response rates and short progression-free survival among patients with pretreated metastatic triple-negative breast cancer.
Meeting News
View All Highlights from Key Oncology Meetings >
ESMO Breast Cancer 2019
ASCO 2019 Annual Meeting
AACR 2019 Annual Meeting
Patient Resources
View All Patient Resources >
Understanding Advanced Breast Cancer: Patient Tear Pad
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla blandit ornare elit, vitae placerat urna interdum non. Aliquam maximus, libero quis viverra pretium, elit ex viverra lacus, ac porta dui ipsum vel quam.
Quizzes
View All Quizzes >
Take the Quiz: Breast Cancer
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla blandit ornare elit, vitae placerat urna interdum non. Aliquam maximus, libero quis viverra pretium, elit ex viverra lacus, ac porta dui ipsum vel quam.
Take the Quiz: Lung Cancer
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla blandit ornare elit, vitae placerat urna interdum non. Aliquam maximus, libero quis viverra pretium, elit ex viverra lacus, ac porta dui ipsum vel quam.
Loading